# Cerillion Latest Research Highlights Potential Strong H2 says Singer

- Link: https://www.directorstalkinterviews.com/cerillion-latest-research-highlights-potential-strong-h2-says-singer/4121192190
- Published: 2025-04-14T10:23:55+01:00
- Author: Anthony Fox

**[Cerillion plc](https://www.directorstalkinterviews.com/company/cerillion-plc/cer.l)**(
[LON:CER](https://www.directorstalkinterviews.com/company/cerillion-plc/cer.l)) 
is poised for a strong second half, according to the latest research by Singer Capital
Markets. Despite a year-on-year revenue decline in the first half of FY25, the telecoms
software provider is expected to rebound significantly, underpinned by solid existing
customer relationships and a robust expansion pipeline.

Singer Capital Markets highlights that Cerillion expects to report £20.9m in H1 
revenue, compared to £22.5m the previous year. However, margins remain resilient
with EBITDA of £10m at an impressive 48%. According to analyst Harold Evans, this
outcome was made possible by “improved Services day-rates, which compensated for
lower licence sales,” with renewals and expansions expected to be concentrated in
H2.

A standout growth opportunity includes a significant expansion with a major European
customer—believed to be Norlys following its acquisition of Telia Danmark. This 
deal could see Cerillion’s BSS/OSS platform manage nearly 1.9 million additional
mobile customers, a boost that underscores the company’s strong positioning in the
market.

“Consider that CER is well placed to meet (or even exceed) FY25 consensus EBITDA(
£22.0m) even in the absence of a further new win,” Evans stated, pointing to the
strength of Cerillion’s recurring revenue from existing clients. He notes that more
than 85% of the company’s income typically comes from current customers, making 
its financial outlook notably stable.

The research further explains that fluctuations between half-year periods are not
unusual for Cerillion, given the timing of revenue recognition on large contracts.
Evans advises not to “over-obsess” over the H1 numbers, stressing that “growth has
not been linear” and pointing to visible prospects for H2, including the $11.4m 
Ucom contract and two other major wins from FY24 expected to go live soon.

With shares currently trading at 1300p, Singer Capital Markets maintains a 12-month
target price of 1900p—a potential upside of 46.2%. The stock is also trading at 
its lowest P/E multiple for five years, signalling what the broker sees as a strong
buying opportunity.

**On a Final Note**, Cerillion’s continued focus on existing customer expansions,
alongside a “very strong” new business pipeline, puts it in a solid position to 
deliver sustainable growth. Investors may find the current valuation compelling,
particularly given the resilience shown in challenging half-year conditions.

Share on:
